Project Grant R01AI182423
Award Date
8/12/24
Completion Date
7/31/25
Dollars Obligated
$1.1M
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Colorado, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $781,685 to The Children's Hospital of Philadelphia Research Institute over 5 years starting December 2024. The funding supports research to understand the molecular circuits controlling human T follicular regulatory (Tfr) cell development and how Tfr cell defects contribute to autoimmune and immunodeficiency...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $468,000.00 to the University of Colorado-Denver to conduct research on the regulation and function of tissue-resident eosinophils, which play a key role in allergic and inflammatory diseases. The research aims to elucidate the factors enabling eosinophil differentiation, how differentiated eosinophils interact with...
This Project Grant award, valued at $379,609.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The project aims to investigate how B cells establish tolerance to commensal microbial antigens, using a mouse model system expressing B cell receptors (BCRs) specific for a model commensal antigen, lipopolysaccharide (LPS). The research will formally define the mechanisms by which a ubiquitous...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $837,497 to Yale University to conduct research focused on understanding the role of PI3K-gamma in regulating antibody responses. The 5-year project aims to elucidate the molecular mechanisms by which PI3K-gamma signaling in B cells supports the differentiation of antibody-secreting cells. The research has important implications for enhancing...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under CFDA 93.855 Allergy and Infectious Diseases Research, provides $189,150.00 to the University of Colorado-Denver to identify new mediators of proinflammatory cytokine signaling. The project aims to perform genome-wide genetic screens to identify factors that mediate the inhibitory effects of cytokines like IL-1β and TNFα on the AKT signaling pathway, which regulates various physiological...
This Project Grant award, ID R21AI190507, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The $264,750 award will fund research to explore the molecular regulation and functional impact of integrin CD11a on the positioning and interactions of lymph node-resident dendritic cells (DC1) with migratory dendritic cells. This research aims to enhance understanding of cellular organization in...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $416,121.00 to Rutgers, The State University of New Jersey to conduct research on the role of Tbet+ B cells in viral reinfection. The research aims to elucidate how the developmental origin of Tbet+ B cells (germinal center vs. extrafollicular) influences their differentiation and function following secondary viral...
This $737,502 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to investigate the role of the WDFY4 protein in regulating antigen presentation by dendritic cells and its impact on regulatory T cell (Treg) development and function. The key objectives are to: 1) Determine the effect of WDFY4 on the T cell receptor repertoire, particularly in Tregs, to...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 2-year Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) worth $162,000 to The Johns Hopkins University to study how atypical B cells can be used to enhance vaccine responses in immunosuppressed individuals. The research project aims to define populations of immunosuppressed individuals who utilize these atypical CD11c+ B cells, assess their interaction with T cells, and target fatty acid oxidation...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $606,501.00 to Northwestern University to elucidate the epigenetic control of germinal center B cell differentiation by the BAF chromatin remodeling complex. The research aims to examine the roles of inflammatory signatures associated with the loss of the ARID1A subunit in disrupting germinal center...